Randomized Clinical Trials Face Practical and Ethical Challenges
The need to revise the design, performance and interpretation of clinical research to reflect changing methods and standards is drawing increased attention.
EMA’s Future Location Remains in Doubt After Brexit Vote
The uncertainty surrounding where the agency and its 890-member staff will call home next may linger for months, if not years.
Europe Tackles New Rules for Non-Clinical to Clinical Handoff
A look at the EMA’s proposed guidance revisions for first-in-human studies.
eConsent Study Provides Insights to Shape Industry Adoption
Janssen releases key findings from its pilot study evaluating the use of electronic informed consent technology in clinical trials.
Patient Centric MS Trial Results
A patient-centric approach to a Phase IV trial for an MS treatment resulted in lessons that can be applied to future therapeutic studies for this and other rare diseases.
Innovations in Patient Matching
More precision models in connecting patients to clinical trials and treatment options are vying to close the ever-elusive recruitment gap.
The Pluses and Minuses of Innovation
Survey delves deep into what constitutes true game-changing innovation in clinical development.
It’s Time to Transform Clinical Trial Operations
The need to move beyond a point-solutions approach to one built around applications designed to manage the end-to-end clinical trial process is crucial.
Africa a Ripe Proving Ground for Digital Health
A proposed operational framework to support digital- and mHealth-based clinical trials in Africa.
The Data-Decision Debate: To Share or Not to Share?
Exploring the benefits from cross-company data sharing for study planning and investigator selection.
Phase III Trial Failures: Costly, But Preventable
An examination of recent failures in Phase III studies and innovative approaches to reduce risk.
Insights Into Capturing Collaborative Value
Research reveals a need for sponsors to be much more consistent, disciplined and focused in their CRO usage.
Interexpert Agreement on Adverse Events’ Evaluation
Study measures the differing judgment levels between clinical investigators and drug safety experts.
Applied Clinical Trials, August/September 2016 Issue (PDF)
Click the title above to open the Applied Clinical Trials August/September 2016 issue in an interactive PDF format.
2 Commerce Drive Cranbury, NJ 08512